Background/Aims: Exogenous surfactant has been proposed as adjunctive therapy for acute respiratory distress syndrome (ARDS), but it is inactivated by different factors present in the alveolar space. We hypothesized that co-administration of LASSBio596, a molecule with significant anti-inflammatory properties, and exogenous surfactant could reduce lung inflammation, thus enabling the surfactant to reduce edema and improve lung function, in experimental ARDS. Methods: ARDS was induced by cecal ligation and puncture surgery in BALB/c mice. A sham-operated group was used as control (CTRL). After surgery (6 hours), CTRL and ARDS animals were assigned to receive: (1) sterile saline solution; (2) LASSBio596; (3) exogenous surfactant or (4) LASSBio596 plus exogenous surfactant (n = 22/group). Results: Regardless of exogenous surfactant administration, LASSBio596 improved survival rate and
Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome

Introduction
Acute respiratory distress syndrome (ARDS) is still a life-threatening disease in critically ill patients, and despite recent advances in critical care and significant efforts invested in basic and clinical research, its mortality rate remains high [1] , with sepsis regarded as the leading cause [2, 3] . Therapeutic strategies have been proposed; nevertheless, studies on pharmacological therapy have yielded controversial results [4] [5] [6] .
Exogenous surfactant has been used as an adjunctive therapy in ARDS [7] due to surfactant dysfunction [8] . However, exogenous surfactant is inactivated by different factors present in the alveolar space, such as proteases released by inflammatory cells, thus limiting its use in clinical practice [9] [10] [11] [12] [13] . Therefore, a pharmacological strategy able to preserve the integrity of surfactant in the alveolar space is required to better optimize its use. In this context, corticosteroid associated with exogenous surfactant, aiming to reduce inflammation, yielded promising results in experimental ARDS [14] . However, controversies remain regarding the use of corticosteroids in ARDS [4] , with particular concerns for mortality rate, ventilator-free and shock-free days, infectious complications, and neuromuscular weakness [4, 15] .
LASSBio596, structurally designed as a hybrid of thalidomide and sildenafil, has demonstrated major anti-inflammatory and immunomodulatory effects [16] . Our group reported the use of LASSBio596 to treat ARDS induced by E.coli lipopolysaccharide [17] . This compound effectively reduced pulmonary inflammation in experimental lung injury induced by endotoxin [17] and microcystin-LR [18, 19] , and elastase induced emphysema [20] .
In the present study, we hypothesized that LASSBio596 associated with exogenous surfactant could reduce the inflammatory process, thus enabling the surfactant to reduce edema and improve lung function, in experimental ARDS induced by sepsis. Therefore, we aimed to compare the effects of LASSBio596, exogenous surfactant, and an association thereof (particularly on the lungs, although distal organs were analyzed as well) to evaluate whether these therapies would exert the same beneficial effects in the present ARDS model.
Materials and Methods
This study was approved by the Ethics Committee of the Health Sciences Center, Federal University of Rio de Janeiro. All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the U.S. National Academy of Sciences.
Animal preparation and experimental protocol
Male BALB/c mice (n = 176, weight 20 -25g) were randomly allocated into 2 main groups. Experimental ARDS was triggered by using a model of cecal ligation and puncture (CLP) surgery [21] to induce sepsis. Briefly, animals were anesthetized with intraperitoneal (i.p.) injection of ketamine and xylazine (0.25 mg/ kg and 0.025 mg/kg, respectively) and a midline laparotomy (2-cm incision) was performed. The cecum was carefully isolated to prevent damage to blood vessels and ligated with a 3-0 cotton suture. The ligature was placed below the ileocecal valve to prevent bowel obstruction. Finally, the cecum was punctured twice with an 18-gauge needle and the animals left to recover from anesthesia [21, 22] . In Sham surgery, the abdominal cavity was opened and the cecum was isolated without ligation and puncture (CTRL group). Mice were fasted for 16 hours before surgery in both groups. Postoperative care was similar in both groups, and consisted of a subcutaneous injection of tramadol hydrochloride (20 mg/g body weight) in 1 mL warm (37°C) normal saline (NaCl 0.9%).
CTRL and ARDS animals were randomly assigned across subgroups (n = 22/subgroup), 6 hours after surgery, to receive: (1) sterile saline solution (SAL, 0.2 mL i.p.); (2) LASSBio596 (596, 10 mg/kg i.p.); (3) exogenous surfactant (S, Survanta ® [beractant], Abbott, Brazil; 100 mg/kg, 4 ml/kg saline intratracheally [i.t.]); and (4) LASSBio596 plus exogenous surfactant (596-S, 10 mg/kg i.p., and 4 mL/kg i.t., respectively). For surfactant administration, animals were anesthetized with sevoflurane (Sevorane ® , Cristália, Itapira, SP, Brazil), supported in an upright position, the trachea was carefully exposed, and warm (37°C) exogenous surfactant was instilled i.t., followed immediately by a 1-mL air bolus to ensure distal distribution. The animal was then placed back in the supine position and a continuous flow of oxygen [3 L/min, fraction of inspired oxygen (FiO 2 ) = 1] was administered until return of normal spontaneous breathing.
At 24 h, lung mechanics and histology were analyzed in 48 mice [n = 6/subgroup], while total and differential cell counts in bronchoalveolar lavage fluid (BALF), blood, and peritoneal fluid, as well as proinflammatory and pro-fibrogenic markers in BALF, were evaluated in a second group of 48 animals [n = 6/ subgroup]. Survival studies were performed in the remaining 80 mice. [n = 10/subgroup].
Survival Rate
All mice had free access to water and food and were monitored for 7 days by the investigators. During this period, all animals received tramadol hydrochloride via subcutaneous injection every 6 hours for pain management. At the 6-hour time points, we evaluated whether animals were close to death, in which case euthanasia was performed immediately to prevent further suffering. Animals that died before euthanasia were under analgesia.
Lung Mechanics
At 24-h hours, after return of spontaneous breathing, animals were sedated (diazepam 1 mg i.p.), anesthetized (thiopental sodium 20 mg/kg i.p.), tracheotomized, paralyzed (vecuronium bromide, 0.005 mg/kg i.v.), and ventilated with a constant flow ventilator (Samay VR15; Universidad de la Republica, Montevideo, Uruguay) set to the following parameters: frequency 100 breaths/min, tidal volume (V T ) 0.2 mL, and FiO 2 0.21. The anterior chest wall was surgically removed and a positive end-expiratory pressure (PEEP) of 2 cmH 2 O applied. After a 10-min ventilation period, airflow and tracheal pressure (Ptr) were measured [23, 24] . Lung mechanics were analyzed using the end-inflation occlusion method [25] . In an open chest preparation, Ptr reflects transpulmonary pressure (P L ). Briefly, after end-inspiratory occlusion, there is an initial fast drop in P L (ΔP 1 ) from the preocclusion value down to an inflection point (P i ), followed by a slow pressure decay (ΔP 2 ), until a plateau is reached. This plateau corresponds to the elastic recoil pressure of the lung (P el ). ΔP 1 selectively reflects the pressure used to overcome the airway resistance. ∆P 2 reproduces the pressure spent by stress relaxation, or viscoelastic properties of the lung, together with a small contribution of pendelluft. Static lung elastance (E st ) was determined by dividing P el by V T . Lung mechanics measurements were obtained 10 times in each animal. All data were analyzed using the ANADAT data analysis software (RHT-InfoData, Inc., Montreal, Quebec, Canada). The total duration of lung mechanics measurements was 10 minutes.
Histology
Light Microscopy of Lungs. After data collection, animals were euthanized by sodium thiopental injection (50 mg/kg i.v.). A laparotomy was performed and heparin (1,000 IU) was injected into the vena cava. The trachea was clamped at end-expiration (PEEP = 2 cmH 2 O) and the abdominal aorta and vena cava were sectioned, yielding a massive hemorrhage that quickly killed the animals. The left lung was then removed, fixed in 3% buffered formaldehyde and paraffin-embedded. Sections (4 µm thick) were cut and stained with hematoxylin and eosin.
Lung histological assessment was performed using an integrating eyepiece with a coherent system consisting of a grid with 100 points and 50 lines of known length coupled to a conventional light microscope (Olympus BX51, Olympus Latin America-Inc., Brazil). The volume fraction of the lung occupied by normal and collapsed alveoli (alveoli with rough or plicate walls) were determined by the point-counting technique [26] across 10 random, non-coincident microscopic fields [27] at x200 magnification. Neutrophils and mononuclear (MN) cells and lung tissue were evaluated at x1000 magnification. Points falling on neutrophils and MN cells were counted, and divided by the total number of points falling on tissue area in each microscopic field. Collagen fibers were quantified in alveolar septa using the Picrosirius-polarization method [28] .
Electron Microscopy of Lungs. Fragments (n = 3, 2x2x2-mm) were cut from 3 different segments of the right lung and fixed (2.5% glutaraldehyde and phosphate buffer 0.1 M, pH = 7.4) for electron microscopy (JEOL 1010 Transmission Electron Microscope, Tokyo, Japan) analysis. On each electron microscopy image (n = 20/animal), the following forms of structural damage were analyzed: a) type I epithelial cell injury, b) type II epithelial cell injury, c) denudation of basement membrane, d) alveolar collapse, and e) endothelial cell damage. Pathology findings were graded on a 5-point, semi-quantitative, severity-based scoring system as follows: 0=normal lung parenchyma, 1=changes in 1 to 25% of examined tissue, 2=changes in 26 to 50% of examined tissue, 3=changes in 51 to 75% of examined tissue, and 4=changes in 76 to 100% of examined tissue [29] .
Apoptosis Assay of Lung and Distal Organs. Terminal deoxynucleotidyl transferase biotin-dUTP nick end labelling (TUNEL) staining was performed in a blinded fashion by two pathologists to assay cellular apoptosis [27] . 10 fields per section from regions with cell apoptosis were examined at x400 magnification. Again, a 5-point semi-quantitative severity-based scoring system was used to assess the degree of apoptosis, graded as: 0 = normal lung parenchyma; 1 = 1-25%; 2 = 26-50%; 3 = 51-75%; and 4 = 76-100% of examined tissue.
Measurement of surface tension
A common method for measuring surface tension is the sessile drop method [30] . The surface tension of a liquid can be obtained from the shape and size of a sessile drop resting on a horizontal surface. Briefly, samples obtained from 5 different segments of the right lung were fragmented. The resulting small fragments were sequentially fixed or not with 2.5% glutaraldehyde in 0.01 M phosphate-buffered 0.15 M NaCl at pH 7.4 (PBS), washed in PBS, and dried in air (or not). These samples were then processed for contact angle (Ɵ) measurements, which were obtained in a Contact Angle Goniometer (Rame-Hart Inc., Mountain Lakes, NJ, USA) attached to an Image Analyzer (Rame-Hart Inc., Mountain Lakes, NJ, USA). The liquids (10-µL drops) used at the air-lung sample-liquid interface were water, hexadecane, propylene, and α-bromonaphthalene, with surface tensions of 72.8 mN/m, 27.5 mN/m, 35.4 mN/m, and 44.4 mN/m respectively. Measurements (n = 10) were obtained with each liquid. The higher the contact angle, the lower the surface tension value, and vice-versa.
Bronchoalveolar and Peritoneal Lavage Fluids and Blood
For collection of BALF and peritoneal lavage fluid (PLF), mice were euthanized by exsanguination (blood was collected with a heparinized needle through the abdominal vein) and BALF was collected by flushing the lungs 3 times with 0.5 ml of 37°C sterile, pyrogen-free saline solution (0.9% NaCl) via the tracheal cannula [21] . After BALF collection, the samples were centrifuged (420 g at 4°C for 15 min), and the supernatant was stored (-70°C) for subsequent analysis of total and differential cellularity, cytokine levels, and lipid and protein content. The cell pellets were resuspended in 1 ml PBS and total cell counts were obtained in a Neubauer chamber. For differential cell counts (macrophages/monocytes, and neutrophils in BALF, PLF, and blood), Cytospin slides were prepared and stained by the May-Grünwald-Giemsa method. Tumor necrosis factor (TNF)-α, Interleukin (IL)-6, KC (murine analogue of IL-8), and transforming growth factor (TGF)-β were quantified in the BALF by ELISA in accordance with manufacturer instructions (Duo Set, R&D Systems, Minneapolis, MN) [21] . All analyses were performed in a blinded fashion.
Lipid Content of Bronchoalveolar Lavage Fluid
Aliquots of BALF (1 mL) were used for total lipid extraction, which was performed as previously described [31] . Briefly, solvent (CHCl 3 -MeOH-HCl, 20:10:0.075 vol/vol, 5.0 ml) was added to the BALF in conic glass tubes and vigorously mixed using a Pasteur pipette. After 10 min on ice, 1.0 ml of HCl (0.6 M) was added, followed again by vigorous mixing with the Pasteur pipette ensued. The tubes were centrifuged (600 g for 10 min); the resulting lower phase (containing the lipids) was carefully moved into another glass tube, washed twice with CHCl 3 -MeOH-0.6 M HCl (3:48:47 vol/vol, 1.0 ml), and centrifuged (600 g for 10 min). The upper phase was removed, and the lower phase was dried under N 2 . Total lipid content was determined gravimetrically. Total lipids were solubilized in a final concentration of 10 mg/ml.
Protein Content and Immunoblotting in the Bronchoalveolar Lavage Fluid
Protein content in BALF was determined by the Folin-phenol method [32] . For Western immunoblotting analysis, 1.0 mL of BALF was centrifuged at 7,000×g for 10 min to remove cells, and then at 11,000×g for 40 min. The supernatant was removed, and the pellet, containing surfactant proteins (SP)-A and SP-D, was resuspended in 100 µL of running buffer. Samples were loaded on a gel, subjected to electrophoresis, and the proteins transferred to a nitrocellulose membrane. The blot was blocked in 5% milk in PBS with 0.1% Tween 20 (PBST, Fisher Scientific, Pittsburgh, PA, USA) for 1 h at room temperature. Rabbit anti-SP-A and SP-D antisera (Anti-SP-A and Anti-SP-D, Santa Cruz Research Antibodies, Santa Cruz, CA, USA) were diluted (1:500) in PBST and applied to the blot for 1 h at room temperature. The blot was washed in PBST, and peroxidase-labeled goat anti-rabbit secondary antibody (Santa Cruz Research Antibodies, Santa Cruz, CA, USA) diluted (1:5,000) in 5% milk in PBST was applied for 30 min at room temperature. The blot was washed in 5% milk in PBST, then in PBST, and finally in PBS. The location of SP-A and SP-D was identified by enhanced chemiluminescence (ECL) (Amersham Biosciences, Uppsala, Sweden), following kit instructions. The densities of the individual bands were compared by densitometry using Scion Image Software (Scion Corporation, Frederick, MD, USA).
Blood Biochemistry for Assessment of Kidney and Liver Function
Urea, creatinine, aspartate transaminase (AST), and alanine transaminase (ALT) were measured using an autoanalyzer (Gold Analisa Diagnostic Ltda., Brazil).
Statistical Analysis
Sample size calculation was based on effect estimates obtained from a previous study using LASSBio-596 [18] . A sample size of 6 animals per group (allowing for one animal as dropout) would provide the appropriate power (1-β = 0.8) to identify significant (α = 0.05) differences in static lung elastance between injured and treated groups with LASSBio596, taking into account an effect size d = 1.66, a twosided test, and a sample size ratio = 1 (G*Power 3.1.9.2, University of Düsseldorf, Germany). To ensure that 6 animals would be available for final analyses and taking into account an expected survival rate of around 60%, we induced CLP injury in an additional 4 animals. The Kolmogorov-Smirnov test with Lilliefors' corrections was used to test for normality of data, while the Levene median test was used to evaluate the homogeneity of variances. Parametric data were assessed using one-way analysis of variance (ANOVA) followed by the Tukey post-hoc test. Survival curves were derived by the Kaplan-Meier method and compared by log-rank test. Nonparametric data were analyzed using ANOVA on ranks followed by Dunn's post-hoc test. Parametric data were expressed as mean ± standard deviation (SD), while nonparametric data were expressed as median (interquartile range). All tests were performed in the GraphPad Prism v5.00 statistical software package (GraphPad Software, La Jolla, California, USA). A two-sided p-value < 0.05 was considered significant.
Results
Survival Rates
Since no significant differences were observed among CTRL groups (CTRL-SAL; CTRL-596; CTRL-S and CTRL-596-S) (data not shown), they were pooled and a single control group (CTRL) was used. All animals survived the initial 6-h period after ARDS induction, with the first deaths occurring only after 18 hours. Analysis of survival rates over 1 week showed that 50% of ARDS animals treated with saline survived, and use of surfactant alone led to no significant benefit. However, LASSBio596, associated or not with surfactant, significantly increased survival rates (to 66% and 70% respectively) as compared with saline (Fig. 1) .
Lung Mechanics and Histology
In the CTRL group, therapy with surfactant and LASSBio596 (the latter associated or not with surfactant) did not lead to changes in lung mechanics (Fig. 2) , histology, or electron Fig. 1 . Kaplan-Meier curves of animals stratified by group: saline (SAL), LASSBio596 (596), surfactant (S), or LASSBio596 combined with surfactant (596-S) treatment after cecal ligation and puncture surgery (ARDS); or sham surgery (CTRL). Since no significant differences were observed between the CTRL-SAL, CTRL-596, CTRL-S, and CTRL-596-S groups, only one control group was considered. Data represent percent survival of CTRL, ARDS-SAL, ARDS-596, ARDS-S, and ARDS-596-S animals (n = 20/group).
Fig. 2. Lung mechanics. Values are means ± SD of six animals in each group. (A) Static lung elastance (Est, L). (B)
Stacked bars chart plot data in which gray bars represent the resistive pressure (∆P1,L), and white bars, the viscoelastic/inhomogeneous (∆P2,L) pressure. The whole column represents the total pressure (∆Ptot, L) variation in each group. Acute respiratory distress syndrome was induced by cecal ligation and puncture surgery (CLP). A sham-operated group was used as control (CTRL) for animals undergoing CLP. At 6 hours, the CTRL and ARDS groups were treated with saline (SAL), LASSBio596 (596), surfactant (S), or LASSBio596 combined with surfactant (596-S). Lung mechanics were analyzed at 24 hours. * Significantly different from CTRL group (p < 0.05). ** Significantly different from ARDS-SAL group (p < 0.05). Table 1 . Lung Histology. Values are means ± SD of 6 animals in each group. Data were gathered from 10 random, non-coincident fields of view per mice. Acute respiratory distress syndrome (ARDS) was induced by cecal ligation and puncture (CLP) surgery. A sham-operated group was used as control (CTRL) for animals undergoing CLP. After surgery (6 hours), CTRL and ARDS groups were treated with saline (SAL), LASSBio596 (596), surfactant (S), or a combination of LASSBio596 and surfactant (596-S). MN, mononuclear cells; TOT, total cells. * Significantly different from CTRL group (p < 0.05). ** Significantly different from ARDS-SAL group (p < 0.05). † Significantly different from ARDS-S group (p < 0.05) Fig. 3 . Electron microscopy of lung parenchyma in CTRL, ARDS-SAL, ARDS-596, ARDS-S, and ARDS-596-S animals at 24 hours. Acute respiratory distress syndrome was induced by cecal ligation and puncture surgery (CLP). A sham-operated group was used as control (CTRL) for animals undergoing CLP. At 6 hours, the CTRL and ARDS groups were further randomized into subgroups to receive saline (SAL), LASSBio596 (596), surfactant (S), or LASSBio596 combined with surfactant (596-S). In the CTRL group, type II pneumocytes (PII) were well preserved, with numerous lamellar bodies and typical microvilli projecting from the cell surface. The integrity of the endothelial cell (E) and alveolar space (A) was evident. ARDS-SAL animals exhibited apoptosis of PII and type I pneumocytes (PI). Note the absence of microvilli and welling of lamellar bodies. Treatment prevented such changes, however, as observed in the ARDS-596 and ARDS-596-S groups. Note the presence of edema (*) in ARDS-S. Photomicrographs are representative of data obtained from lung sections derived from 5 animals. Table 2 . Semi-quantitative analysis of lung electron microscopy. Values are median (interquartile range) of 5 animals in each group. A 5-point semi-quantitative severity-based scoring system was used. Pathology findings were graded as: 0 = normal lung parenchyma; 1 = 1-25%; 2 = 26-50%; 3 = 51-75%; and 4 = 75-100% of examined tissue. Acute respiratory distress syndrome (ARDS) was induced by cecal ligation and puncture (CLP) surgery. A sham-operated group was used as control (CTRL) for animals undergoing CLP. After surgery (6 hours), CTRL and ARDS groups were further randomized into subgroups to receive saline (SAL), LASSBio596 (596), surfactant (S), or a combination of LASSBio596 and surfactant (596-S). * Significantly different from CTRL group (p < 0.05). ** Significantly different from ARDS-SAL group (p < 0.05). † Significantly different from ARDS-S (p < 0.05) turned to CTRL values regardless of therapy (Fig. 2) . The ARDS-SAL group exhibited areas of alveolar collapse, infiltration of mononuclear cells and neutrophils in alveolar and interstitial spaces, and alveolar septal thickening ( Table 1 ). The fraction area of alveolar collapse and the number of mononuclear cells and neutrophils was reduced to the same extent in all treated groups (Table 1) . Collagen fiber content was increased in ARDS-SAL compared to CTRL and reduced in ARDS-596 and ARDS-596-S, but did not change in ARDS-S (Table 1) . Ultrastruc-tural analysis of lung parenchyma showed damage to type I and II epithelial cells, with necrosis and apoptosis, denudation of basement membrane, disorganization of the extracellular matrix, fibroblast proliferation, and presence of interstitial edema, alveolar collapse, and endothelial cell damage (Fig. 3, Table 2 ). LASSBio596, associated or not with surfactant, attenuated these lung ultrastructural changes. Even though surfactant therapy decreased type I and II epithelial cell damage and interstitial edema, no significant reduction in endothelial cell damage was observed (Fig. 3, Table 2 ). 
Cell Apoptosis
The number of apoptotic cells in the lung, liver, kidney, and enteric villi was higher in ARDS-SAL than in the CTRL group. LASSBio596, associated or not with surfactant, reduced the number of apoptotic cells in lung and distal organs. Therapy with surfactant alone did not affect the number of apoptotic cells in lung, liver, kidney, and enteric villi (Table 3) .
Total and Differential Cell Counts in BALF, PLF, and Blood
The total number of cells, macrophages/monocytes, and neutrophils in BALF, PLF, and blood was higher in ARDS-SAL compared to CTRL animals (Fig. 4) . The total number of cells, neutrophils, and macrophages/monocytes in BALF, PLF, and blood was lower in ARDS-596 and ARDS-596-S than ARDS-SAL animals. Surfactant reduced the total number of cells, neutrophils, and macrophages only in the BALF.
Pro-Inflammatory and Pro-Fibrogenic Mediators in the BALF
TNF-α, IL-6, KC, and TGF-β levels were higher in ARDS-SAL compared to CTRL animals. TNF-α and IL-6 levels were reduced in all treated groups, whereas KC decreased only in the ARDS-596-S group. The TGF-β level was reduced in ARDS-596 and ARDS-596-S groups, similar to CTRL; however, no major difference was observed between the ARDS-S and ARDS-SAL groups (Fig. 5) .
Lipid and Protein Content in BALF
ARDS-SAL animals had lower lipid but higher protein contents in BALF compared to CTRL animals. LASSBio596 plus exogenous surfactant led to increased lipid content in the BALF. LASSBio596, associated or not with surfactant, decreased protein content in the BALF (Fig. 6) , suggesting a reduction in alveolar capillary damage. The relative amounts of SP-A and SP-D were decreased in ARDS-SAL (4-fold and 5-fold those of CTRL animals), and these values were restored regardless of therapy. 
Surface Tension
Surface tension was investigated by analyzing the contact angles formed on the biological surface. Considering the CTRL group as a standard measurement, in the presence of water, ARDS-SAL and ARDS-596 animals displayed lower contact angles, thus suggesting higher surface tension. The ARDS-S and ARDS-596-S groups presented surface tension similar to CTRL (Table 4 ). In the presence of liquid with the lowest surface tension (hexadecane), ARDS-S animals had surface tension values similar to those of CTRL animals. In the presence of propylene and α-bromonaphthalene, all ARDS groups, independent of treatment, showed lower contact angles compared to CTRL group, thus suggesting higher surface tension (Table 4) .
Kidney and Liver Function
Serum urea, creatinine, AST, and ALT were increased in ARDS-SAL compared to CTRL animals (Fig. 7) . The ARDS-596 and ARDS-596-S groups exhibited urea and creatinine values similar to those of CTRL animals. These markers were attenuated in ARDS-S compared to ARDS-SAL animals. AST and ALT reduced regardless of treatment protocol. available (as Survanta ® ) and widely used in neonatal respiratory dysfunction [42] . Beractant is a natural bovine lung extract containing 25 mg/mL phospholipids, of which 11-15.5 mg/ mL are disaturated phosphatidylcholine, plus neutral lipids and fatty acids. The protein content consists of two hydrophobic, low-molecular-weight, surfactant-associated proteins, commonly known as SP-B and SP-C. These surfactant proteins have been shown to exert anti-inflammatory effects in distinct settings [43] [44] [45] .
In the present model of ARDS, LASSBio596 (administered i.p.), surfactant (administered i.t.), and LASSBio596 plus surfactant reduced changes in lung mechanics, which may be attributed to a reduction in alveolar collapse and edema, airway edema, and inflammation. Additionally, all these therapies reduced liver dysfunction. Similarly, in experimental lung injury induced by endotoxin [17] and microcystin-LR [18, 19] , i.p. administration of LASSBio596 has been shown to reduce pulmonary functional impairment and TNF-α. Oral administration of LASSBio596 prevented lung and hepatic inflammation and completely blocked pulmonary functional and morphological changes induced by microcystin-LR in a previous study [18] . Therefore, LASSBio596 has been demonstrated to exert beneficial effects on lung function and morphology regardless of the route of administration and experimental model of lung injury.
Therapy with surfactant reduced surface tension, which restored elastic recoil close to CTRL values. In the presence of liquids with the highest surface tension (H 2 O) and the lowest levels of surface tension (hexadecane), treatment with surfactant was able to restore contact angles (reduced surface tension) to near-CTRL values. However, therapy with LASSBio596 and LASSBio596 plus surfactant did not lead to similar behavior, particularly in the presence of hexadecane. LASSBio596 has a carboxylic acid terminus [16] , which may interact with phospholipids, especially dipalmitoylphosphatidylcholine, the main constituent of alveolar surfactant [46] ; therefore, with this interaction, the expected decrease in active surface tension at the air-liquid interface may not happen, due to persistence of hydrogen bonds in the air-liquid interface.
Increased levels of pro-inflammatory mediators were observed in the model of ARDS used in this study, as has been reported in preclinical [21, 22] and clinical studies [47] . TNF-α and KC not only amplify the inflammatory process but also recruit neutrophils into the lung [48] [49] [50] . Intraperitoneal administration of LASSBio596, but not of surfactant, was able to reduce the number of inflammatory cells in PLF and blood. On the other hand, the beneficial effects of surfactant, whether associated with LASSBio596 or alone, were observed in the BALF and in lung tissue, where surfactant, through tracheal delivery, might exert its anti-inflammatory properties locally. Previous studies have shown that the i.p. and i.v. pharmacokinetic profiles of LASSBio596 are closer in rodents [51] , with a half-life ~7h, and high bioavailability, closer to 95%. We believe that the therapeutic window was optimized to counteract the intense inflammatory process induced after CLP. In the present study, LASSBio596 decreased pulmonary edema formation and neutrophil migration, which may be attributed to a reduction in proteases that functionally altered surfactant lipids and proteins through a decrease in TNF-α-mediated mechanisms [14] .
LASSBio596 played an important role in counteracting the remodeling process, which started early in the course of lung injury [17, 29] . Treatment with surfactant alone was not able to reduce TGF-β levels or percentage of collagen fibers in lung tissue, perhaps because the proteases present in lung edema may degrade surfactant, thus reducing its anti-inflammatory effectiveness and maintaining fibroblast activation and fibrogenesis. Lipid production was higher with LASSBio-596 plus surfactant compared to individual therapy. We believe that, as inflammatory pathways are downregulated, constitutive type II pneumocyte metabolism recovered, allowing synthesis, production, and release of surfactant components, such as lipids.
Kidney protection was observed in the presence of LASSBio596, regardless of whether it was administered with exogenous surfactant. This may result in improved survival, as acute kidney injury is regarded as the main cause of mortality in sepsis [52] . Due to the aforementioned anti-inflammatory effects, LASSBio-596 was able to reduce distal organ dysfunction as well.
Even though the administration of surfactant alone reduced changes in lung mechanics and histological damage, it was unable to reduce the increased number of neutrophils in the blood or have an impact on kidney and liver apoptosis, thus resulting in no modification in survival rate.
Some limitations of this study should be mentioned. First, this mild model of ARDS was induced by CLP as a model of sepsis. Thus, our results cannot be extended to other experimental models of sepsis or ARDS, nor can they be extrapolated to different degrees of severity or directly to the clinical scenario. Second, we evaluated the effects of different therapies 24 h after sepsis-induced ARDS; thus, we do not know what effects might have occurred late in the course of lung injury. Third, LASSBio596 was administered intraperitoneally and as a single dose 6 hours after ARDS induction, and different effects may result depending on the route of administration and timing of injection. Finally, a single dose of surfactant was administered 6 hours after ARDS induction. One could argue that factors such as severity of lung injury, type of exogenous surfactant, dose, frequency, and method of administration might influence the response to therapy.
Conclusion
LASSBio596, structurally designed as a hybrid of thalidomide and sildenafil, exhibited major anti-inflammatory and immunomodulatory effects, thus representing a potential therapeutic tool for ARDS induced by sepsis. LASSBio-596 plus surfactant may provide further advantages related to lipid content, potentially reducing surface tension.
